International, prospective haemovigilance study on methylene blue-treated plasma.

L Noens, Ma D Vilariño, A Megalou, H Qureshi

Vox Sanguinis（2017）

引用 5|浏览2

暂无评分

摘要

Methylene blue plasma has a very acceptable safety profile with a rate of serious adverse reactions of 0·5/10 000 units.

查看译文

关键词

blood safety,haemovigilance,methylene blue,pathogen reduction

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要